BridgeMD
New treatment option for Chronic Inflammatory Bowel Diseases
Official title Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,
ClinicalTrials.gov ID: NCT07529236
What this study is testing
What is switch of anti TNF for ustekinumab for paradoxical psoriasis.?
switch of anti TNF for ustekinumab for paradoxical psoriasis. is an investigational medicine, being studied as a potential treatment for chronic inflammatory bowel diseases.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Inflammatory bowel diseases (IBD) include Crohn's disease (CD) and ulcerative colitis (UC). They cause abdominal pain and chronic diarrhea and/or rectal bleeding, which can lead to weight loss and malnutrition.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 17
You may be able to join if
- Patients capable of giving their non-opposition
- Patient \<19 years
- Diagnosis of IBD established
- Having received an anti-TNFα for IBD for at least 3 months
- Having stopped the anti-TNFα for a severe paradoxical psoriasis resistant to usual treatments (topical or systemic) diagnosed by a dermatologist
You likely can't join if
- Patient \> 18 years
- Diagnosis of IBD not confirmed
- Discontinuation of anti-TNFα for a cause other than psoriasis
See the full eligibility criteria
- Patients capable of giving their non-opposition
- Patient \<19 years
- Diagnosis of IBD established
- Having received an anti-TNFα for IBD for at least 3 months
- Having stopped the anti-TNFα for a severe paradoxical psoriasis resistant to usual treatments (topical or systemic) diagnosed by a dermatologist
- Having received Ustekinumab in relay of the anti-TNFα
- Patient \> 18 years
- Diagnosis of IBD not confirmed
- Discontinuation of anti-TNFα for a cause other than psoriasis
The study team makes the final eligibility decision.
Where it's taking place
- Nice, France, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, France, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.